Thymic cancer
Conditions
Interventions
Sponsors
West Japan Oncology Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Histologically confirmed thymic carcinoma. 2)Clinically confirmed Masaoka stage III, IVa or IVb not amenable to potentially curative therapy by surgery or radiotherapy. 3)Patients without prior chemotherapy. 4)Recurrence after surgery or radiotherapy but recurrent sites have never been irradiated. 5)Measurable lesion 6)Adult patients (20 years of age or more than 20) 7)Performance status 0-1 8)Adequate organ function 9)Written informed consent
Exclusion criteria
Exclusion criteria: 1)Presence of pleural or pericardial effusion that cannot be controlled by a procedure. 2)Presence of brain tumor with clinical symptoms. 3)Superior vena cava syndrome. 4)Interstitial pneumonitis. 5)Presence of other active malignancy. 6)Acute intercurrent infection or complications 7)History of serious allergy to medical drugs. 8)Uncontrolled psychiatric disease. 9)pregnancy or lactating patients 10)Myasthenia gravis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective response rate (RECIST criteria) | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival, Progression survival, Safety | — |
Countries
Japan
Contacts
Public ContactShinichiro Nakamura
West Japan Oncology Group WJOG datacenter
Outcome results
None listed